Considering the low specificity of AAV8 targeting vascular epithelial cells, it is necessary to change AAV serotypes and assess the editing effectiveness of targeting Vegfr2 and the therapeutic effect of reducing Vegfr2 expression in vascular epithelial cells after wet AMD onset in a subsequent study. This evidence concerns the gene KDR and wet macular degeneration.